Last Round
Series B
Mar 31, 2026
Total Funding Raised
$250M
Company Overview
Syneron Bio is a biotechnology company that develops next-generation macrocyclic peptide therapeutics for oncology and chronic diseases using its proprietary Synova™ platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Syneron Bio Comps
Public and private peers based on sector, stage, and business model.
Syneron Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 31, 2026 | ||||
| Series A | Dec 18, 2025 | ||||
| Pre Seed | Mar 13, 2023 |
Syneron Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series B |
| Biotech Development Fund | Series B |
| True Light Capital | Series B |
| GL Ventures | Series B |
| Decheng Capital | Series B |
| Pfizer Biotech Development Investment Fund | Series A |
| 5Y Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
$150M round raised
Syneron Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Syneron Bio's valuation, stock price, and market status.
